Fact CheckerSign in

NCT05488782Completed

TEAM-Red, a Remotely Delivered Self-management Program for Depressed Black Women at Risk for Hypertension

A Pilot RCT of a Remotely Delivered Self-management Program (TEAM-Red) for Depressed Young African American Women at Risk for Hypertension (HTN)

Source: ClinicalTrials.gov · Last updated 28 Apr 2026

Brief summary (registry, in English)

The proposed project is a 24-week prospective randomized controlled trial (RCT) evaluating the effects of TargEted MAnageMent Intervention (TEAM, N=41) vs. enhanced waitlist (eWL, N=41) control in young (\<50 years) African American women who are depressed or suffering from stress, and at risk for hypertension.

Status (registry)
Completed
Study type
Interventional
Enrollment
83 (actual)
First submitted
3 Aug 2022
Start date
Jan 2023
Primary completion date
Sept 2025
Lead sponsor
Jennifer B. Levin
NCT number
NCT05488782

What you commit to

  • Study type: Interventional
  • Participants enrolled: 83
  • From Jan 2023 to the primary completion date, Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Phase 1 Inclusion Criteria:
  • Registered on Research Goes Red;
  • Self-identified African American female ages 18-49;
  • current depression as measured by a score of ≥10 on the 9-item Patient Health Questionnaire (PHQ-9),
  • Have at least one of the following self or chart-recorded HTN risk factors: body mass index (BMI) greater ≥ 30, HbA1c \>5.75, at least one outpatient reading of systolic blood pressure (BP) ≥ 130 mm Hg or diastolic ≥90 mmHg, current smoker, or LDL ≥100 mg/dl in the last 12 months;
  • Are able to participate in study procedures.
    • Phase 1 Exclusion Criteria:
  • Unwilling/unable to provide informed consent;
  • Pregnancy;
  • Imminent suicide risk,
  • A current diagnosis of hypertension or use of antihypertensive medications.
    • Phase 2 Inclusion Criteria
  • Self-identified AA female ages 18-49;
  • Endorses either: a past or current history of depression, current depression as measured by a score of at least a 5 on the 9-item Patient Health Questionnaire (PHQ-9), or indicate feelings of stress or discrimination that impact their functioning
  • Have at least one of the following self or chart-recorded HTN risk factors: BMI greater ≥ 30,26 HbA1c \>5.75,27 at least one outpatient reading of systolic BP ≥ 130 mm Hg or diastolic ≥90 mmHg, current smoker, or LDL ≥100 mg/dl in the last 12 months;
  • Are able to participate in study procedures.
    • Phase 2 Exclusion Criteria
  • Unwilling/unable to provide informed consent;
  • Pregnancy;
  • Imminent suicide risk,
  • A current diagnosis of HTN or use of antihypertensive medications.

Age in the registry: 18 years to 49 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospitals Cleveland Medical Center*
Coordinator of this site? Confirm its status
ClevelandUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.